Status:
COMPLETED
Hull Airway Reflux Questionnaire Scores Following Cough Treatment
Lead Sponsor:
Hull University Teaching Hospitals NHS Trust
Conditions:
Cough
Eligibility:
All Genders
18-75 years
Brief Summary
The aim of this study is to have those patients taking part in the Clinical trial-: A Multicentre, Double-Blind, Placebo-Controlled, Pivotal Study of the Efficacy and Safety of Oral Theobromine in the...
Eligibility Criteria
Inclusion
- Male/females meeting eligibility criteria for study: - A Multi-centre, Double-Blind, Placebo-Controlled, Pivotal Study of the Efficacy and Safety of Oral BC1036 in the Management of Cough.
- Willing and able to comply with study procedures
- Able to provide written informed consent to participate
Exclusion
- 1\. Any subject meeting any exclusion criteria on the study "A Multi-centre, Double-Blind, Placebo-Controlled, Pivotal Study of the Efficacy and Safety of Oral BC1036 in the Management of Cough." Will be excluded from this study.
Key Trial Info
Start Date :
January 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2013
Estimated Enrollment :
57 Patients enrolled
Trial Details
Trial ID
NCT01515280
Start Date
January 1 2012
End Date
July 1 2013
Last Update
July 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hull and East Yorkshire Hospitals Trust
Cottingham, East Riding Of Yorkshire, United Kingdom, HU16 5JQ